levodopa/carbidopa low dose (ND0612L) / Mitsubishi Tanabe  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levodopa/carbidopa low dose (ND0612L) / Mitsubishi Tanabe
NCT02782481 / 2016-002033-30: A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

Withdrawn
3
0
RoW
ND0612, Levodopa/Carbidopa solution, Placebo, Placebo solution
NeuroDerm Ltd.
Parkinson's Disease
10/18
10/18

Download Options